According to Insulet's latest financial reports and stock price the company's current number of shares outstanding is 69,823,000. At the end of 2023 the company had 69,823,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 69.82 M | 0.51% |
2022 | 69.47 M | 0.58% |
2021 | 69.07 M | 4.74% |
2020 | 65.94 M | 5.69% |
2019 | 62.39 M | 5.58% |
2018 | 59.09 M | 1.48% |
2017 | 58.23 M | 1.39% |
2016 | 57.43 M | 0.88% |
2015 | 56.93 M | 1.37% |
2014 | 56.16 M | 2.73% |
2013 | 54.67 M | 13.39% |
2012 | 48.21 M | 1.68% |
2011 | 47.42 M | 18.1% |
2010 | 40.15 M | 43.37% |
2009 | 28 M | 1.05% |
2008 | 27.71 M | 5.29% |
2007 | 26.32 M | 7302.89% |
2006 | 0.35 M | -55.29% |
2005 | 0.79 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 3,347.57% | ๐บ๐ธ USA |
Abbott Laboratories ABT | 1,734,076,358 | 2,383.53% | ๐บ๐ธ USA |
Medtronic MDT | 1,329,700,000 | 1,804.39% | ๐ฎ๐ช Ireland |
Eli Lilly LLY | 949,379,000 | 1,259.69% | ๐บ๐ธ USA |
Tandem Diabetes Care
TNDM | 65,117,000 | -6.74% | ๐บ๐ธ USA |
ICU Medical
ICUI | 24,132,000 | -65.44% | ๐บ๐ธ USA |
DexCom DXCM | 390,200,000 | 458.84% | ๐บ๐ธ USA |